<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Controversy exists regarding the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE) epsilon4 allele association with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), ranging from increased epsilon4 frequency, similar to that found for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), to no association between the epsilon4 allele and VaD </plain></SENT>
<SENT sid="1" pm="."><plain>To clarify further the relationship between ApoE alleles polymorphism and cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> and cognitively impaired patients, we examined the ApoE phenotypes in a sample of 280 patients: 155 with AD, 21 with VaD, 32 with mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (MD), 45 with mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) but without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, and 27 in which <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> was the most probable cause of <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> [vascular mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (VMCI)] </plain></SENT>
<SENT sid="2" pm="."><plain>Our results show that the frequency of the ApoE epsilon4 allele in patients over 70 years old with clinically diagnosed VaD and VMCI does not differ significantly from that of controls </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, ApoE epsilon4 allele-bearing individuals had greater risk of having <z:hpo ids='HP_0003584'>late-onset</z:hpo> AD (OR = 8.8; 95% CI 3.7-21.0), or non-vascular <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (OR = 7.0; 95% CI 2.5-19.0) </plain></SENT>
</text></document>